Clincosm LogoSign in Get a demo

brain metastases

Showing 76 - 100 of 269
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Metastases Trial in Louisville (intraoperative radiotherapy (IORT))

Terminated
  • Brain Metastases
  • intraoperative radiotherapy (IORT)
  • Louisville, Kentucky
    University of Louisville, James Graham Brown Cancer Center
May 17, 2022

LIFE - Lung Cancer, Immunotherapy, Frailty, Effect

Active, not recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • CT-scans extended
  • +3 more
  • Odense, Denmark
    Department of Oncology, Odense University Hospital
May 17, 2022

Malignant Melanoma, Brain Metastases Trial in Tucson (E6201, E6201 plus dabrafenib)

Terminated
Has Results
  • Malignant Melanoma
  • Brain Metastases
  • Tucson, Arizona
    University of Arizona Cancer Center
Mar 5, 2022

Brain Metastases, Nsclc Trial in Heidelberg (SRS, Whole Brain Radiotherapy)

Recruiting
  • Brain Metastases
  • Nsclc
  • SRS
  • Whole Brain Radiotherapy
  • Heidelberg, Germany
    University Hospital of Heidelberg, Radiation Oncology
May 13, 2022

NSCLC, EGFR Activating Mutation, Brain Metastases Trial in Beijing (TY-9591 Tablets)

Recruiting
  • NSCLC
  • +3 more
  • TY-9591 Tablets
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospitial,Chinese Academy of Medic
May 14, 2022

Brain Metastases Trial (MRI perfusion sequence)

Not yet recruiting
  • Brain Metastases
  • MRI perfusion sequence
  • (no location specified)
May 9, 2022

Brain Metastases Trial in Dallas (Stereotactic Radiosurgery)

Recruiting
  • Brain Metastases
  • Stereotactic Radiosurgery
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Apr 29, 2022

Brain Metastases Trial in Toronto (Hyperpolarized 13C-Pyruvate)

Recruiting
  • Brain Metastases
  • Hyperpolarized 13C-Pyruvate
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
May 4, 2022

Brain Tumor, Brain Metastases Trial in Toronto (Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI))

Recruiting
  • Brain Tumor
  • Brain Metastases
  • Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI)
  • Toronto, Ontario, Canada
    University Health Network
May 2, 2022

Breast Cancer, Brain Metastases Trial in Guangzhou (Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant)

Recruiting
  • Breast Cancer
  • Brain Metastases
  • Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant
  • Guangzhou, Guangdong, China
  • +1 more
Apr 24, 2022

Brain Metastases Trial (SRT, fSRT)

Not yet recruiting
  • Brain Metastases
  • SRT
  • fSRT
  • (no location specified)
Apr 20, 2022

Glioblastoma, Brain Metastases Trial in Oslo (Losartan)

Recruiting
  • Glioblastoma
  • Brain Metastases
  • Oslo, Norway
    Oslo University Hospital
Apr 22, 2022

NSCLC With EGFR Mutation, Brain Metastases Trial in China (Keynatinib)

Recruiting
  • Non-Small Cell Lung Cancer With EGFR Mutation
  • Brain Metastases
  • Beijing, Beijing, China
  • +4 more
Apr 17, 2022

Astrocytoma, Brain Cancer, Brain Metastases Trial in Kogarah, Liverpool (QBS10072S)

Recruiting
  • Astrocytoma
  • +22 more
  • Kogarah, New South Wales, Australia
  • +1 more
Apr 18, 2022

Brain Metastases Trial in Toronto, Berlin (Stereotactic Radiosurgery)

Recruiting
  • Brain Metastases
  • Stereotactic Radiosurgery
  • Toronto, Ontario, Canada
  • +1 more
Apr 14, 2022

Brain Metastases Trial in Canada, United States (drug, radiation, procedure)

Recruiting
  • Brain Metastases
  • Tucson, Arizona
  • +72 more
Apr 6, 2022

Brain Metastases, Adult, Brain Metastases, Brain Cancer Trial in Miami (18F fluciclovine)

Recruiting
  • Brain Metastases, Adult
  • +2 more
  • 18F fluciclovine
  • Miami, Florida
  • +1 more
Apr 11, 2022

Brain Metastases Trial in Milwaukee (Memantine -Twice Daily or Extended Release, WBRT utilizing the PRDR technique)

Recruiting
  • Brain Metastases
  • Memantine -Twice Daily or Extended Release
  • WBRT utilizing the PRDR technique
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Apr 5, 2022

Brain Metastases Trial in France (Preoperative SRS)

Recruiting
  • Brain Metastases
  • Preoperative SRS
  • Clermont-Ferrand, Puy-de-Dôme, France
  • +7 more
Apr 7, 2022

Brain Metastases Trial in Boston (NTS-WBRT (normal tissue sparing whole brain radiation therapy), HA-WBRT (hippocampal avoidance

Recruiting
  • Brain Metastases
  • NTS-WBRT (normal tissue sparing whole brain radiation therapy)
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Apr 7, 2022

Brain Metastases Trial in Birmingham (Dose Escalated Five Fraction Stereotactic Radiosurgery)

Recruiting
  • Brain Metastases
  • Dose Escalated Five Fraction Stereotactic Radiosurgery
  • Birmingham, Alabama
    Hazelrig-Salter Radiation Oncology Center
Mar 25, 2022

NSCLC, Leptomeningeal Metastases, Brain Metastases Trial in United States (Tesevatinib)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • +2 more
  • Beverly Hills, California
  • +6 more
Mar 7, 2022

NSCLC, Brain Metastases, EGFR Mutation Trial in Guangzhou (Gefitinib and Pemetrexed/platinum, Gefitinib mono-therapy)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Gefitinib and Pemetrexed/platinum
  • Gefitinib mono-therapy
  • Guangzhou, Guangdong, China
    Sun Yat-sen University of Cancer Center
Feb 19, 2022

Breast Cancer, Brain Metastases Trial in United States (Whole Brain Radiotherapy (WBRT), Sorafenib)

Completed
  • Breast Cancer
  • Brain Metastases
  • Basking Ridge, New Jersey
  • +5 more
Mar 4, 2022

Brain Metastases, Small Cell Lung Cancer Trial in Birmingham (NovoTTF-200A, Stereotactic Radiosurgery (SRS))

Terminated
  • Brain Metastases
  • Small Cell Lung Cancer
  • NovoTTF-200A
  • Stereotactic Radiosurgery (SRS)
  • Birmingham, Alabama
    University of Alabama at Birmingham (UAB), Hazelrig-Salter Radia
Feb 17, 2022